Current Opinion in Microbiology

(The H4-Index of Current Opinion in Microbiology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)
Antibiotics: past, present and future784
Global epidemiology of emerging Candida auris156
Horizontal transfer of antibiotic resistance genes in the human gut microbiome152
Candida albicans biofilm growth and dispersal: contributions to pathogenesis121
Candidalysin: discovery and function in Candida albicans infections115
The evolution and transmission of multi-drug resistant Escherichia coli and Klebsiella pneumoniae: the complexity of clones and plasmids95
Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy92
Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms87
PANoptosis in microbial infection78
Neonatal gut microbiome and immunity75
The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine69
Hepatitis E virus: host tropism and zoonotic infection62
Recent and emerging technologies for the rapid diagnosis of infection and antimicrobial resistance57
Unlocking the trove of metabolic treasures: activating silent biosynthetic gene clusters in bacteria and fungi55
Linking bacterial growth, survival, and multicellularity – small signaling molecules as triggers and drivers53
Engineering enzymatic assembly lines to produce new antibiotics50
The antiviral activities of TRIM proteins46
Mycoviruses and their role in fungal pathogenesis45
The social life of microbes in chronic infection44
When is a transcription factor a NAP?44
The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae44
Regulatory mechanisms controlling morphology and pathogenesis in Candida albicans41
The potential of using E. coli as an indicator for the surveillance of antimicrobial resistance (AMR) in the environment40
Natural products discovery and potential for new antibiotics39
The assembly of β-barrel outer membrane proteins38
PAS domains in bacterial signal transduction37
Extracellular vesicles of human pathogenic fungi37
The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria37
Pseudomonas aeruginosa polymicrobial interactions during lung infection36
A titanic drug resistance threat in Cryptococcus neoformans35
Seizing the moment: now is the time for integrated global surveillance of antimicrobial resistance in wastewater environments35
Immunoglobulin A and the microbiome35
Toward computer-made artificial antibiotics34
Translocation of effector proteins into host cells by Toxoplasma gondii34